Data / Form D filings / Annovis Bio, Inc.
Annovis Bio, Inc.: Form D filings
Annovis Bio, Inc., a biotechnology company in Berwyn, PA, filed 10 Form D notices with the SEC between 2010 and 2023. The latest, on April 25, 2023, reports $1.1 million sold of a $1.1 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1055 WESTLAKES DRIVE, SUITE 300, Berwyn, PA, 19312
- Phone
- (610) 727-3913
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1477845
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | New notice | $1,064,952 | $1,064,952 | 6 | Apr 7, 2023 | sec.gov | |
| Mar 15, 2019 | New notice | $530,000 | $530,000 | 9 | Mar 4, 2019 | sec.gov | |
| Dec 22, 2017 | New notice | $1,000,000 | $324,000 | $676,000 | 6 | Dec 15, 2017 | sec.gov |
| Oct 26, 2016 | New notice | $799,200 | $799,200 | 14 | Oct 11, 2016 | sec.gov | |
| Jun 5, 2015 | Amendment | $1,067,360 | $1,067,360 | 21 | May 22, 2015 | sec.gov | |
| Jan 5, 2015 | New notice | $1,000,000 | $500,000 | $500,000 | 1 | Dec 19, 2014 | sec.gov |
| Dec 30, 2013 | Amendment | $1,550,000 | $450,000 | $1,100,000 | 13 | Jun 6, 2013 | sec.gov |
| Jun 20, 2013 | New notice | $350,000 | $350,000 | 12 | Jun 6, 2013 | sec.gov | |
| Apr 26, 2010 | New notice | $2,056,103 | $706,103 | $1,350,000 | 3 | Apr 14, 2010 | sec.gov |
| Jan 15, 2010 | New notice | $1,000,000 | $150,000 | $850,000 | 2 | Jan 4, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Claudine Bruck | Director | |
| Mark White | Director | |
| Reid McCarthy | Director | |
| Michael Hoffman | Director | |
| Henry Hagopian | Executive Officer | |
| Maria Maccecchini | Executive Officer, Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Apr 24, 2023 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Annovis Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.